| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.017 | 0.9 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |